|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131 IDR | +4.80% |
|
+3.97% | -17.09% |
PT Millennium Pharmacon International Tbk reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was IDR 2,439,791.69 million compared to IDR 2,393,386.78 million a year ago. Net income was IDR 26,730.55 million compared to IDR 23,841.74 million a year ago.
Basic earnings per share from continuing operations was IDR 20.98 compared to IDR 18.71 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -17.09% | 10.21M | |
| +55.32% | 815B | |
| +44.05% | 641B | |
| -6.75% | 352B | |
| +13.56% | 314B | |
| +10.68% | 303B | |
| +16.57% | 242B | |
| +2.04% | 224B | |
| +13.31% | 218B | |
| +8.48% | 168B |
PT MILLENNIUM PHARMACON INTERNATIONAL TBK 
